HISTOLAB PRODUCTS ApS: Financial statements 2022
CVR: 28292090
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HISTOLAB PRODUCTS ApS (CVR 28292090) has filed annual accounts for 2022. In 2022, the company reported revenue of DKK 13,108,612 and a net result of DKK 56,754 compared with DKK 68,320 the year before. That is a decrease of 2.5% compared with the year before. The profit margin was 0.4%. Equity in the 2022 report amounted to DKK 2,896,157. The solvency ratio was 66.6%. The company had 1 employee in the financial year.
- Revenue
- DKK 13,108,612
- Gross Profit
- DKK 1,054,976
- Profit/Loss
- DKK 56,754
- Equity
- DKK 2,896,157
- Total Assets
- DKK 4,349,432
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | 13.1 mio. | 1.1 mio. | 57 t. | 2.9 mio. | 1 |
| 2021 | 13.4 mio. | 1.2 mio. | 68 t. | 2.8 mio. | 1 |
| 2020 | 12.3 mio. | 1.8 mio. | 546 t. | 2.8 mio. | 1 |
| 2019 | 8.5 mio. | 1.3 mio. | 269 t. | 2.2 mio. | 1 |
| 2018 | 8.2 mio. | 1.5 mio. | 375 t. | 2 mio. | 1 |
Official annual report
Keep an eye on HISTOLAB PRODUCTS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HISTOLAB PRODUCTS ApS has published its annual report for 2021. Revenue came to DKK 13,442,231, and the net result was DKK 68,320.
About HISTOLAB PRODUCTS ApS
HISTOLAB PRODUCTS ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2004. The company is registered under the industry Agenturhandel med specialiseret varesortiment, bortset fra køretøjer. The company was previously named ALGOL PHARMA ApS. The management consists of Caj Patrik Joakim Eurenius. The board consists of Caj Patrik Joakim Eurenius (chair) and Frida Birgitta Ekstrand. The company is owned by Histolab Products AB. The company has 1 employee (2026). In 2025, the company reported revenue of DKK 14,888,720 and a net result of DKK 107,970 compared with DKK 59,499 the year before. Equity in the 2025 report amounted to DKK 3,130,036.